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Equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) glycoprotein H (gH) has been hypothesized to play a role in
direct fusion of the virus envelope with cellular membranes. To investigate gH’s role in infection, an EHV-1 mutant
lacking gH was created and the gH genes were exchanged between EHV-1 and EHV-4 to determine if gH affects
cellular entry and/or host range. In addition, a serine-aspartic acid-isoleucine (SDI) integrin-binding motif present in
EHV-1 gH was mutated as it was presumed important in cell entry mediated by binding to α4β1 or α4β7 integrins.
We here document that gH is essential for EHV-1 replication, plays a role in cell-to-cell spread and significantly affects
plaque size and growth kinetics. Moreover, we could show that α4β1 and α4β7 integrins are not essential for viral
entry of EHV-1 and EHV-4, and that viral entry is not affected in equine cells when the integrins are inaccessible.Introduction
Equine herpesviruses 1 and 4 (EHV-1 and EHV-4) con-
tain a linear, double-stranded DNA genome and belong
to the subfamily Alphaherpesvirinae in the Herpesviridae
family. Within the genus Varicellovirus, 17 distinct virus
species can be identified [1], among them EHV-1 and
EHV-4 which are antigenically and genetically closely
related [2]. Comparison of the complete DNA sequence
of EHV-4 and EHV-1 showed a high degree of similarity
that results in a 55 to 96% amino acid identity between
proteins of the two viruses. EHV-1 and EHV-4 gH share
an amino acid identity of 85% [3]. Despite the similarities
with respect to genetic makeup and overall biology,
EHV-1 and EHV-4 cause strikingly different pathogenesis
beyond the respiratory tract and the observed general
malaise following infection.
Initially, EHV-1 infection occurs in epithelial cells of
the upper respiratory tract, then the virus spreads to local
lymphatic tissues and infects mononuclear cells, which
enter the bloodstream and cause productive leukocyte-
associated viremia [4-6]. From infected peripheral blood* Correspondence: wfazab@zedat.fu-berlin.de
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reproduction in any medium, provided the ormononuclear cells (PBMC), EHV-1 can initiate viral rep-
lication in endothelial cells (EC) lining the small blood
vessels of either the nervous system or uterus causing
neurological disorders or abortion, respectively [2,7].
EHV-4, on the other hand, generally remains confined to
the upper respiratory tract, although the virus has been
studied in much less detail than EHV-1. EHV-4 is not
commonly associated with leukocyte-associated viremia,
infection of PBMC, abortions, or paresis [2,7]. The
reduced pathogenic potential of EHV-4 has been attribu-
ted to differences in cellular tropism between EHV-1 and
EHV-4, since EHV-4 can only infect respiratory epithelial
cells and not vascular EC in vivo [7]. Under experimental
conditions, EHV-1, but not EHV-4, can infect a broad
range of host cells [8]. However, it was recently shown
that there was no significant difference in the ability of
EHV-1 and EHV-4 to infect equine EC in vitro [7,9].
As with other alphaherpesviruses, EHV-1 entry into
cells is presumed to require five viral envelope glycopro-
teins (gC, gB, gD and the heterodimer gH/gL) and is
mediated through different cell surface receptors [9-13].
Depending on the type of cell infected, entry of EHV-1
can occur via endocytosis or fusion at the plasma mem-
brane [6,14,15]. Among herpesviral glycoproteins gB, gH,
and gL are conserved across all herpesviruses and, con-
sequently, essential for virus entry and cell fusion. Several
studies suggested that gH/gL itself has fusogenic propertiesd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tures of herpes simplex virus type 2 (HSV-2) gH/gL,
Epestein-Barr virus (EBV) gH/gL, and pseudorabies virus
(PRV) gH revealed that gH/gL does not resemble any
known fusion protein. Instead, it may act as a fusion
regulator [18-21]. The structural studies showed that gH
has three distinct domains with the N-terminal domain
(domain H1) shown to bind to gL [20]. It has long
been known that, in the case of EBV and HSV, gL is
required for correct folding, trafficking, and function of
gH [19,22]. How gB and gH/gL function and interact
during alphaherpesviral fusion is still not fully under-
stood. Recent studies suggest that fusion is a stepwise
process starting with gD binding to its cognate receptors,
followed by activation of gH/gL to prime gB for fusion
[23,24].
Integrins are heterodimeric cell adhesion receptors
that mediate cellular interactions with the extracellular
matrix and surrounding cells, which serve as receptors
for many viruses [25,26]. An integrin-binding motif
present in gD of EHV-1, arginine-serine-aspartic acid
(RSD), was shown to facilitate endocytosis through inter-
actions with αVβ5 in CHO-K1 or αVβ3 in PBMC. How-
ever, the motif present in gD of EHV-4, RSN, does not
lead to significant PBMC infection [6]. That being said,
even when this motif was mutated in EHV-1, infection of
PBMCs was never completely abolished, meaning that
endocytosis and infection of PBMCs is a complex, multi-
step process, which may require other viral glycoproteins
and cell surface molecules.
One of these glycoproteins may be gH, which harbors a
motif similar to that shown to mediate binding of rota-
viruses to α4 integrins [27,28]. The amino acid motif
leucine-aspartate-valine (LDV) is the primary binding
site for α4β1 integrins in fibronectin, and the related
motif, leucine-aspartate-isoleucine (LDI), has been
shown to bind α4 integrins as well [27,28]. The most re-
markable feature of α4 integrin-binding sites is the pres-
ence of an aspartate residue next to a hydrophobic
residue on the amino- or carboxy-terminal side of aspar-
tate [29]. Therefore the serine-aspartate-isoleucine (SDI)
sequence found at amino acid residues 457–459 in EHV-1
possibly represents an α4 binding motif. EHV-4, on the
other hand, has a single nucleotide substitution at pos-
ition 447 relative to EHV-1, which changes this motif
to alanine-aspartate-isoleucine (ADI). Interestingly, α4
integrins are dominantly and highly expressed on B and
T lymphocytes as well as on monocytes [30].
We here investigated the role of EHV-1 and EHV-4 gH
in infection, cellular entry and/or host range and integrin
binding. To this end, the gH genes were exchanged
between EHV-1 and EHV-4 via two-step Red-mediated
recombination of infectious clones of either virus [31]. In
addition, the putative SDI integrin-binding motif withinEHV-1gH was mutated as it was hypothesized to be




EHV-1 strain L11Δgp2 and recombinant WA79 derived
from an infectious EHV-4 BAC clone were generated
and used as described before [32,33].
Plasmids
Transfer plasmids encoding either EHV-1 or EHV-4 gH
with a kanamycin-resistance (kanR) gene were con-
structed. All primers used are listed in Table 1. EHV-1 or
EHV-4 gH genes were amplified by polymerase chain re-
action (PCR) using primers P1, P2, P3, and P4 (Table 1),
respectively. PCR products were digested with restriction
enzymes and inserted into the pcDNA3 vector (Invitro-
gen, Darmstadt, Germany), resulting in recombinant
plasmids pcDNAgH1 and pcDNAgH4. To construct
pcDNAgH1-Kan and 4-Kan, the kanR gene was amplified
from the pEPkan-S plasmid [31] using primers P5, P6, P7
and P8 (Table 1). PCR products were digested and
inserted into pcDNAgH1 or pcDNAgH4. Correct ampli-
fication and insertion were confirmed by nucleotide
sequencing (Starseq, Mainz, Germany).
Cells
Fetal horse kidney (FHK) cells, kindly provided by Dr V.
Svansson, University of Iceland, human embryonic
kidney (293), RK13, and Vero cells were propagated in
Dulbecco’s modified Eagle’s medium (DMEM, Biochrom,
Berlin, Germany) supplemented with 10% fetal bovine
serum (FBS, Biochrom). Equine dermal (NBL-6) and
CHO-K1 cells were grown in Iscove’s modified Dulbecco’s
medium (IMDM, Invitrogen) supplemented with 10%
FBS. CHO-A, CHO-B, and CHO-C were generously pro-
vided by Dr P. Spear, Northwestern University, Chicago,
IL, and express the HVEM, nectin-2 and nectin-1 recep-
tors, respectively. They were grown in IMDM supple-
mented with 10% FBS and 500 μg/mL G418 (Invitrogen).
PBMC were isolated from heparinized blood collected
from healthy horses as described before [9]. After two
washing steps, cells were resuspended in RPMI 1640
(Biochrom) supplemented with 10% FBS. For generation
of RK13 cells, which constitutively express EHV-1 gH
(RK/gH1), RK13 cells were transfected with the recom-
binant pcDNAgH1 plasmid using Lipofectamine 2000
(Invitrogen) and colonies resistant to G418 (800 μg/mL)
were selected and analyzed by western blotting for expres-
sion of EHV-1 gH. As controls, cells were transfected
with the pcDNA3 vector (RK/vector) and were also main-
tained in medium containing G418.
Table 1 Olignucleotide primers used in this study
Primer Product Sequence





























aRestriction enzyme sites are given in lower case bold letters; sequences in italics indicate additional bases which are not present in the EHV-1 or -4 sequence.
bUnderlined sequences indicate the template binding region of the primers for PCR amplification with pEPkan-S.
cUpper case bold letters indicate the nucleotides that were mutated.
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The anti-mouse DATK32 monoclonal antibody (MAb),
an α4β7 integrin antagonist, and MAb P4C2, an α4β1 in-
tegrin antagonist, were obtained from Biolegend (Fell,
Germany) and Abcam (Cambridge, UK), respectively.
Isotype-matched mouse immunoglobulin G (IgG) was used
as a control (Cell Signaling Technologies, Frankfurt am
Main, Germany). EHV-1 polyclonal anti-gH antibodies
were kindly provided by Dr Antonie Neubauer-Juric,
Bavarian Health and Food Safety Authority, Germany.
BAC Mutagenesis
EHV-1 strain RacL11 cloned as a BAC (pL11) [32] and
EHV-4 BAC clone pYO03 [33] were described earlier.
pL11 and pYO03 BACs were maintained in Escherichiacoli (E. coli) GS1783 cells (a kind gift from Dr Greg
Smith, Northwestern University, Chicago, IL, USA).
Deletion of gH1 and gH4 was done via two-step Red
recombination as previously described [31]. Briefly, PCR
primers, P9, P10, P11, and P12 (Table 1), were selected
such that the 50 nucleotide (nt) recombination arms
enabled the substitution of the gH gene by the kanR gene
at nt 1 to 2546 or 1 to 2567 in EHV-1 or EHV-4, respect-
ively. PCR products were digested with DpnI in order
to remove residual template DNA. Transfer fragments
were then electroporated into GS1783 containing the
BACs. Kanamycin-resistant colonies were purified and
screened by PCR and RFLP to detect E. coli harbor-
ing mutant clones. Positive clones were subjected to a
second round of Red recombination to obtain the final
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the kanR gene.
The transfer constructs gH4Kan and gH1Kan were
amplified by PCR using pcDNAgH4Kan or pcDNAgH1-
Kan templates and primers P13, P14, P15, and P16
(Table 1). PCR products were electroporated into
GS1783 harboring pL11 or pYO03. After selection on LB
agar plates containing 25 μg/mL chloramphenicol and
kanamycin, resistant colonies were purified and screened
by PCR and RFLP to detect E. coli harboring recombin-
ant pL11gH4Kan and pYOgH1Kan. Positive clones were
subjected to a second round of Red recombination to
obtain the final constructs pL11gH4 and pYOgH1.
A point mutation targeting the SDI motif present in
EHV-1 gH was engineered by converting nucleotide 1318
of gH from a thymidine to a guanine, changing the serine
into alanine (gHS440A), by employing two-step Red-
mediated recombination. Primers, P17 and P18, used for
mutant generation are listed in Table 1. The respective
genotypes of all the mutants and revertants were con-
firmed by PCR, RFLP, and nucleotide sequencing using
primers P19-P29 (Table 1).
Generation of recombinant viruses
EHV-1gH4 and EHV-1gHS440A were reconstituted after
transfection of purified BAC DNA into RK13 cells [32].
For EHV-4gH1, the virus was reconstituted by transfec-
tion of purified DNA into 293 cells as described earlier
[33,34]. After three days, the supernatant and cells were
collected and used to infect confluent NBL-6 cells.
Western blot analysis
For western blot analyses, pellets of infected FHK cells or
RK/gH1 were resuspended in radioimmunoprecipitation
assay buffer with a protease inhibitor cocktail (Roche,
Mannheim, Germany). Sample buffer (1M Tris/HCl, pH
6.8; 0.8% sodium dodecyl sulfate (SDS); 0.4% glycerol;
0.15% β-mercaptoethanol; 0.004% bromophenol blue)
was added, the mixture was heated at 95°C for 5 min
and proteins were separated by 10% SDS-polyacrylamide
gel electrophoresis (PAGE) exactly as previously described
[35]. Expression of gH was detected using EHV-1
polyclonal anti-gH antibodies and goat anti-rabbit
IgG coupled to peroxidase (Southern Biotech, Eching,
Germany) as secondary antibodies. A Rabbit anti-β-actin
antibody (Cell signaling Technologies) was included as
a loading control. Reactive bands were visualized by
enhanced chemoluminescence (ECL plus, Amersham,
Freiburg, Germany).
Virus growth assays
To determine viral replication, single-step growth
kinetics and plaque diameter assays were performed as
described before [35,36]. Briefly, confluent NBL-6 cellswere infected at a multiplicity of infection (MOI) of 1
or 0.01 for 1 h at 37°C. Cells were then washed and over-
laid with DMEM with 10% FBS. Infected cultures were
harvested at the indicated times post-infection (pi)
and viral titers were determined by plating onto NBL-6
cells. Plaques were counted and growth kinetics were
determined in three independent experiments. For
plaque size measurements, NBL-6 cells were infected
with viruses (MOI of 0.001) and overlaid at 1 h pi
with DMEM containing 0.5% methylcellulose (Sigma,
Hamburg, Germany). At 3 days pi, 50 fluorescent plaques
were photographed for each virus and average plaque
diameters were calculated using ImageJ software vl.32j
[37]. Values were compared to plaque areas induced by
parental viruses, which were set to 100%. Three inde-
pendent experiments were used to calculate average
plaque sizes and standard deviations.Virus infection assay
For measuring infectivity (efficiency of plating) of recom-
binant viruses, cell monolayers were inoculated with dif-
ferent viruses (MOI 0.1). After 1 h of adsorption, cells
were washed and overlaid with DMEM containing 10%
FBS and infection was allowed to proceed for 48 h. Cells
infected with each virus were monitored and photo-
graphed with an Axiocam CCD camera (Zeiss, Berlin,
Germany).Flow cytometry
To evaluate integrin expression, NBL-6, FHK, and PBMC
cells were incubated with 2 μg/mL of the anti-integrin
MAbs targeting α4β7 (DATK32) or α4β1 (P4C2) or an
isotype control mouse IgG for 1 h at RT. After washing
twice with PBS, cells were incubated with Alexa fluor
488-labeled goat anti-mouse IgG (1/500 dilution) for 1 h
at RT. After a final wash, 10 000 cells were analyzed
using a FACScalibur flow cytometer (BD Biosciences,
Heidelberg, Germany), and the intensity of fluorescence
was analyzed using FlowJo software (Treestar, Olten,
Switzerland).
For infection experiments, 2 × 105 cells were prepared
in 24 well plates as monolayers (NBL-6 and FHK) or as
suspensions (PBMCs). Before adding the antibodies,
media was removed and cells were washed with PBS con-
taining 2% FBS. Cells were incubated with integrin anti-
bodies (20 μg/mL) at 4°C for 1 h [6,9]. Cells were washed
and infected with viruses at an MOI of 2 or 5. NBL-6 and
FHK cells were trypsinized at 24 h pi and washed twice,
while PBMC were washed twice at 48 h pi. After centri-
fugation, cells were resuspended in PBS containing
10 μg/mL propidium iodide (PI; Invetrogen) and the
intensity of fluorescence of 10 000 cells was analyzed to
determine the percentage of infected cells.
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Using Microsoft Excel, Student’s t test for paired data was
used to test for significance. Data given are as mean
values, and bars show standard deviations.
Results
Generation and genotypic characterization of mutant
viruses
Two-step Red-mediated recombination was used to
exchange the gH-encoding sequences between EHV-1
and EHV-4. The newly generated viruses included an
EHV-1 mutant harboring (gH4) in place of gH1, and a
corresponding EHV-4 carrying gH1. Furthermore, EHV-
1 with a point mutation in the SDI motif present in
gH was engineered by changing the serine into alanine
(gHS440A). PCR analysis showed that all constructs har-
bored the desired genetic modifications (data not shown)
and further analysis of the mutant clones was done using
nucleotide sequencing (data not shown). gH1 is locatedFigure 1 Identification of recombinant viruses by RFLP and Western b
EHV-1gHS440A (left panel) as well as EHV-4, EHV-4gH1Kan and EHV-4gH1 (rig
that appeared as a consequence of the deletion or insertion of gH sequen
and EHV-4 gHs’ N-terminal part. The alignment begins with aa49 to aa 327
mutant viruses as well as complementing RK13/gH1 cells express gH at sim
from RK13/gH1 and proteins were separated by SDS-10%-PAGE. The blots
with anti-rabbit IgG peroxidase conjugate. For RK13/gH1 cells (left panel), E
mutants (right panel), two bands of approximately 125 and 115kD were de
a loading control.within a 15.1 kbp SalI fragment, which disappeared and
was replaced by two bands of 8.3 kbp and 6.8 kbp in size
in the case of EHV-1gH4 due to the presence of a SalI
site in the gH4 gene. The presence of the kanR gene, in
EHV-1gH4Kan added 1 kbp to the larger band, and a
fragment of around 9.3 kbp in size, which is difficult to
identify as it comigrated with another, slightly larger frag-
ment (Figure 1a). On the other hand, the gH4 gene is
located in a 10-kbp SacII fragment. Replacement of gH4
with gH1 resulted in two bands of 6.2 kbp and 3.5 kbp is
size as the gH1 sequence contains two SacII sites. The
6.2 kbp comigrates with several bands around 6 kbp in
the SacII restriction digest of EHV-4. However, the pres-
ence of kanR gene resulted in a higher band of around
7.2 kbp in size in the EHV-4gH1Kan (Figure 1a).
To determine whether gH1 and gH4 were expressed
properly by the mutant viruses, FHK cells were infected
with the respective viruses and infected-cell lysates were
analyzed by western blotting. Our results showed thatlotting. (a) Purified DNA from EHV-1, EHV-1gH4, EHV-1gH4Kan and
ht panel) were digested with SalI and SacII. Fragments in the mutants
ce are marked by arrows. (b) Amino acid sequence alignment of EHV-1
(H1 domain homologue, that binds gL, in HSV-2) [20]. (c) Parental and
ilar levels. Cell lysates were prepared either from infected FHK cells or
were incubated with EHV-1 polyclonal anti-gH antibody and detected
HV-1 and related mutants (middle panel), and EHV-4 and related
tected that are not present in mock-infected cells. β-actin was used as
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viruses including the mutants (Figure 1c).
Virus growth analyses
Three independent growth kinetic experiments and
plaque size measurements were performed using equine
NBL-6 cells. Compared to parental EHV-1, EHV-1gH4
had a significantly reduced growth rate over the 30 h
time course (Figure 2a). In contrast, the growth rate of
EHV-1gHS440A was not significantly different from that
of the parental virus control (Figure 2a). With regard
to the EHV-4-based recombinant, both viruses grew
to almost identical titers in NBL-6 cells (Figure 2b). In
addition, the EHV-1 mutant harboring gH4 produced
plaques significantly smaller in size when compared to
plaques formed by EHV-1 parental virus and reached
only 69% of the plaque diameters relative to those








































Figure 2 In vitro growth characterization of parental and mutant viru
1 or 0.01. Infected cells and supernatants were collected and virus titers we
means ± SD of triplicate measurements. The asterisk indicates a P< 0.05 for
diameters of 50 plaques measured for each virus are shown. The plaque di
a P< 0.05 for means when compared to the parental viruses.by EHV-1gHS440A, on average, reached 98.4% of the size
of parental virus plaques, a reduction that was not sig-
nificant relative to parental virus. We concluded from
the experiments that there was no significant difference
in plaque size due to the mutation of the putative
integrin-binding motif SDI (Figure 2c). In contrast, inser-
tion of gH1 in place of the authentic glycoprotein gH4 in
EHV-4 led to an increase in the average plaque diameter
of the mutant virus, which was 114.3% relative to that
of EHV-4 parental virus (Figure 2d), indicating that gH
may also have a role in cell-to-cell spread.
EHV-1 gH is essential for virus replication
When DNA of EHV-1ΔgH was transfected into RK13,
virus replication remained restricted to a small number
of cells that did not increase over time. Only single
infected cells were detected, and there was no develop-






































ses. (a, b) For growth kinetics, NBL-6 cells were infected at MOI’s of
re determined at the indicated times pi. The data presented are
means when compared to the parental viruses. (c, d) Means ± SD of
ameter of parental viruses was set to 100%. The asterisks indicate
(a) (b)
(c) (d)
Figure 3 Infection of RK13 cells with EHV-1ΔgH. RK13 cells were
transfected with either EHV-1ΔgH DNA (a) or EHV-1 parental DNA
(b). EHV-1ΔgH was also transfected into RK13/gH1 cells (c).
Recovered virus was collected from RK13/gH1 cells and used to
infect naïve RK13 cells (d). Infected cells appear green as all viruses
express EGFP. Cells were inspected with a fluorescent microscope
(Zeiss Axiovert) and images were taken with a CCD camera (Zeiss
Axiocam). The bar represents 100 μm.
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typically resulted in extensive plaque formation after
only 24 h (Figure 3b). Next, DNA of EHV-1ΔgH was
transfected into RK13/gH1 as described above. Here,
complete viral replication was evident and plaques simi-
lar in morphology to those induced by parental virus
developed after 48 h (Figure 3c), although viral growth
was not as robust as was the case for parental EHV-1.
Finally, EHV-1ΔgH virus grown on RK13/gH1 cells was
collected and used to infect naïve RK13 cells. Again, viral
infection remained restricted to single cells (Figure 3d).
In conclusion, our results showed that gH is essential for
EHV-1 replication in vitro.
Type-specific gH has no effect on host range of EHV-1
or EHV-4 in vitro
EHV-1 can be readily propagated in many cell lines
including primary equine cells or cell lines derived
from other species [8]. In contrast, EHV-4 appears to be
restricted mainly to cells derived from horses and repli-
cates poorly in very few other cell lines such as Vero cells
[38]. To test the hypothesis that gH might be a determin-
ant of EHV-1 and EHV-4 host range, gH mutant viruses
were used to examine the ability of the viruses to infect
different cell lines in vitro. Our results showed that gH
has no role in determining the host range of either EHV-
1or EHV-4. EHV-1 parental and mutant viruses were still
able to infect all cell lines that are permissive for EHV-1
and resistant to EHV-4, such as RK13 and CHO-K1(Figure 4). However, viral spread was clearly affected
by gH on RK13 cells, as was the case on NBL-6 cells
(Figure 5a). Infection of Vero cells, which are permissive
for EHV-4 but not EHV-1, showed that EHV-4 and
EHV-4gH1 can infect these cells efficiently, while EHV-1
and EHV-1gH4 only poorly infected these cells (Figure 4).
Finally, we found that HeLa, MDBK, PBMC, EC and
293 cells can be infected with parental and mutant
viruses with similar efficiencies and that viral infec-
tion was independent of gH1 or gH4, respectively
(data not shown).
Integrins are not involved in EHV-1 or EHV-4 entry into
PBMC or equine fibroblast cells
PBMC are highly relevant to EHV-1 pathogenesis as out-
lined above, whereas EHV-4 infection of leukocytes is
reported to be a rare event. It was postulated that the
SDI integrin motif, present in EHV-1 gH but not EHV-4
gH, might be an important determinant for efficient in-
fection of PBMC in vitro [6]. In order to address the hy-
pothesis that gH1 and/or gH4 can affect viral infection of
PBMC, we first infected PBMC with EHV-1 and EHV-4
strains and analyzed the percentages of infected cells by
flow cytometry. Surprisingly, the percentage of infected
PBMC after inoculation with EHV-1 or EHV-4 was nearly
identical, ranging from approximately 3% (MOI=1) to 9%
(MOI=6) (Figure 5a). In a second round of experiments,
we included all of our mutants in the PBMC infection
experiments. As with our previous results, the rate of in-
fection was similar for all viruses used (Figure 5b). Fur-
thermore, we used anti-integrin α4β1 (P4C2) or α4β7
(DATK32) MAb to investigate the role of integrins during
entry into PBMC. First, the proper expression of α4β1 or
α4β7 on PBMC using the function-blocking MAb P4C2
or DATK32 was confirmed (Figure 6a). Both α4β1 and
α4β7 integrins were highly expressed on PBMCs, with
77.5% and 54.8%, respectively, of cells reactive with the
antibodies. α4β1 integrins were also expressed on NBL-6
(40%) and FHK (30%) cells (Figure 6b and c), although
there was no significant expression of α4β1 in either Vero
or CHO-K1 cells (data not shown). The expression of the
α4β7 integrin was minimal in NBL-6, FHK (Figure 6b and
c), Vero or CHO-K1 cells (data not shown), and the mean
fluorescence intensities not significantly different from
that observed with mouse IgG control antibodies. Pre-
incubation of PBMC with either α4β1 or α4β7 integrin-
blocking antibodies did not lower the rate of viral infection
in PBMCs for any of the parental or mutant viruses
tested. Controls without antibodies for each virus were
normalized to 100% and the percentage of infection after
the use of antibodies was compared to this value. After
using the α4β1 blocking antibody, infection rates of
EHV-1 and related mutants were actually increased com-














Figure 4 The role of gH in EHV-1 and EHV-4 cellular tropism. RK13 (a), CHO-K1 (b), CHO-A (c), CHO-B (d), CHO-C (e), or Vero (f) cells were
infected at an MOI of 0.5 with the engineered virus recombinants, all of which express EGFP. At 48 h pi, cells were inspected with a fluorescent
microscope (Zeiss Axiovert) and images were taken with a CCD camera (Zeiss Axiocam). The bar represents 100 μm.
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of the viruses. In the case of EHV-4 there was a slight
decrease in the percentage of infected cells, which was
not significantly different from the average percentage
of infection of the untreated virus. After treating cells
with the α4β7 antibody, all viruses showed no signifi-
cantly increased infection rates of PBMCs compared to
untreated controls. Therefore, the integrin-blocking anti-
body does not have any significant adverse effect either
on viral entry or on viral infection when added to cells
prior to infection.
To further elucidate the role of integrins in virus entry,
we either blocked α4β1 integrins on the surface of NBL-6
and FHK cells or incubated the viruses with soluble α4β1
integrin (15 μg/mL, R&D Systems, Minneapolis, USA)
[39] before infection. Again, this treatment had no sig-
nificant effect on the entry of parental or mutant viruses
(data not shown). We concluded from our data thatPBMC can be infected with similar efficiencies by both
EHV-1 and EHV-4 in vitro. Furthermore, integrins may
serve as a receptor and/or co-receptor for viral entry and
their blockade may not have a measurable effect on virus
infection, especially, if alternative receptors exist.
Discussion
Alphaherpesviruses are successful at spreading directly
from cell-to-cell in epithelial cells and neurons, thus
avoiding the extracellular space and exposure to host
defenses such as neutralizing antibodies. It is clear that
the gE/gI heterodimer plays a major role in cell-to-cell
spread, but gH also facilitates the movement of virus
from infected to uninfected cells [40-42]. However, des-
pite the fact that gH is involved in the process of cell-to-
cell spread in a number of alphaherpesviruses [43], the
actual role of gH in membrane fusion processes has yet
































EHV-1 EHV-4 EHV-1gH4 EHV-4gH1
Figure 5 Infection of equine PBMC with recombinant viruses.
PBMC were incubated with EHV-1 or EHV-4 at an MOI of 1 or 6
(a) for 1 h at 37°C. After 48 h, the percentage of infected cells was
determined by flow cytometry. In another experiment, PBMC were
infected with the engineered mutant viruses (b). The data represent
the mean± SD of at least three independent experiments.
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ques, demonstrating the essentiality of EHV-1 gH in viral
infection. The fact that the number of infected cells does
not increase over time suggests that EHV-1ΔgH is not
able to either enter cells or spread from an infected cell
to adjacent uninfected cells [44]. By contrast, parental
EHV-1 efficiently replicates in RK13 cells, producing a
large number of plaques. The gH deletion virus was only
able to produce plaques when grown in an RK13 cell line
that was created to stably express gH1. A similar result
was observed in the case of PRV and bovine herpesvirus-1
(BoHV-1) deleted in gH, where mutant viruses were un-
able to form plaques in non-complementing cells [42,45].
Furthermore, recombinant EHV-1 in which gH1 was
replaced with gH4 produced significantly smaller plaques
when compared to parental virus, whereas the insertion
of gH1 into the EHV-4 genome led to increased plaque
sizes. As seen above, the absence of gH in EHV-1 led to
the complete abrogation of plaque formation; therefore,
it is reasonable to assume that when gH1 is replaced with
gH4, the mutant virus is less capable of engaging in cell-
to-cell spread.
In a recent study conducted in our lab it was shown
that, as is the case for other alphaherpesviruses, efficient
EHV-1 and EHV-4 entry is mainly dependent on gD,which can bind to several cell surface receptors and
determines the host range of both EHV-1 and EHV-4 [9].
In the study presented here, we found that, in all cells
tested, the exchange of gH did not have an effect on the
entry of the viruses into cells, thus indicating that gH
is probably not important in determining cellular host
range or binding to cellular receptors.
It has been shown that HSV-1 gB and gH/gL are
involved in nuclear egress and fusion between the virion
envelope and the outer nuclear membrane resulting in
de-envelopment of primary enveloped viruses [46]. We,
therefore, considered it likely that EHV-1 gH plays a role
in viral egress, more specifically in the first envelopment
step at nuclear membranes, secondary envelopment at
cytoplasmic membranes, or the release of the virion into
the extracellular space [47]. The fact that the exchange of
gH had such a marked effect on virus cell-to-cell spread
may indicate that there is little room to compensate for
the loss of authentic gH in EHV-1 and/or that gH1 is
much more efficient with respect to facilitating fusion.
Another point of consideration is the covalently linked
heterodimer formed between gH and gL. The crystal
structure of EHV gH has not been determined yet. How-
ever, on the basis of overall similarity, one may derive
some information from other herpesviruses particularly
HSV-2, PRV, and EBV. Biochemical data corroborated by
crystal structure analyses revealed that it is the gL sub-
unit and the N-terminal residues of gH that form the
heterodimeric complex, which is essential for efficient
membrane fusion and viral entry [19-22]. Furthermore, it
has been established that gL is required for proper fold-
ing, intracellular transport, and full functionality of gH.
The accumulated data and knowledge of the gH-gL inter-
action that make it difficult to evaluate the role of one of
these glycoproteins individually as one has to assume
that they will not act independently of each other but
have to be viewed as a functional unit [48-51]. The
N-terminal region of EHV-1 and EHV-4 gH share
approximately 82% amino acid identity (Figure 1b). Per-
haps, authentic gL could compensate for the phenotypic
changes induced by the exchange of the respective gH’s.
It will, therefore, be interesting to examine whether a
double mutant, i.e. EHV-1 harboring gH4-gL4 and vice
versa, would lead to any improvement or possibly even
further impairment of the viruses’ ability to effectively
replicate.
The amino acid motif LDV is the primary binding site
for α4β1 integrins in fibronectin, and the related motifs
LDI or SDI have been shown to bind α4 integrins with
similar affinity and avidity [27-29]. To determine the role
of integrins in viral entry into PBMCs, cells were incu-
bated with antibodies directed against α4β1 or α4β7,
and then infected with parental and mutant viruses. In
PBMCs, none of the viruses were significantly affected by
Figure 6 Integrins have no role in EHV-1 or EHV-4 entry into equine cells. PBMC (a) NBL-6 (b) or FHK (c) cells were incubated with anti-
α4β7 MAb DATK32 or α4β1 MAb P4C2 for 1 h at RT, followed by incubation with Alexa fluor 488-labeled goat anti-mouse IgG for 1 h at RT. As
controls, cells were incubated with irrelevant MAbs of the same IgG isotype. Integrin expression was determined by flow cytometry. (d) PBMC
were preincubated with either α4β7 MAb DATK32 or α4β1 MAb P4C2 for 1 h at 4°C, followed by infection with recombinant viruses at an MOI of
5 for 2 h at 37°C. At 48 h pi, cells were washed and the percentage of infected cells was determined by flow cytometry. The rate of infection of
parental viruses was set to 100%. All data represent the mean± SD of three independent experiments.
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cases, viral entry into the cells was actually increased
compared to cells not treated with antibodies. The same
result was also obtained after blocking α4β1 integrin on
the surface of equine fibroblasts. Furthermore, incubat-
ing either EHV-1 or EHV-4 with soluble α4β1 integrin
before infection did not affect the entry. One may argue
that integrin antibodies or soluble integrins were unable
to block or mask either the integrin receptors on cell
surface or the integrin motif present in gH. However,
our results showed that both blocking integrin recep-
tors and masking the integrin motif directed the virus
to a different entry pathway, indicating reactivity and
functional consequences of the antibodies and the sol-
uble integrins (Azab and Osterrieder, unpublished
data). The results of two recent reports support thefindings of our experiments [9,52]. In these studies, it
was shown that the presence of αVβ3 or αVβ5 integrins
is not a requirement for either gD or gH-gL binding to
different cells.
In summary, we conclude from our experiments that
gH or the gH/gL complex is essential for the formation
of plaques by EHV-1 and that the exchange of gH’s be-
tween EHV-1 and EHV-4 has a measurable impact on
viral growth and plaque sizes. It remains unclear what
this specific role of gH1 and gH4 in cell-to-cell spread
entails, but similar results with related viruses suggest
that the functions of gH and that of the heterodimeric
gH-gL complex are at least partly conserved in the alpha-
herpesvirus subfamily. Lastly, our study has proven that
integrins seem not to be essential for entry of EHV-1 or
EHV-4 in any of the cell types analyzed.
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